Designing a CMC Strategy For Advanced Therapy Medicinal Products (ATMP) in EU

Published on: Oct 1, 2012

Valerie Pimpaneau and Anne Dupraz Poiseau discuss the latest EU guidelines on ATMPs and explain how to develop a solid chemistry, manufacturing and control strategy for such products.

Valérie Pimpanneau, Anne Dupraz-Poiseau

2012 – SCRIP Regulatory Affairs

Download the full resource now

Fill in the form to download the content

Thank you ! Your file is ready to download. Click here to download

Designing a CMC Strategy For Advanced Therapy Medicinal Products (ATMP) in EU

Published on: Oct 1, 2012

MORE RESOURCES

How to Ensure Safety and Efficacy in Medical Device Vigilance via Patient Engagement

Understanding Microbiome Testing Kits: What They Are and How They Are Used

Ask the Experts: Navigating FDA & EMA CMC Expectations for Cell and Gene Therapy Product Development